Heat Biologics Inc. (HTBX): Report on Beta Factor For HTBX

ROTH Capital declared it was Initiated coverage of Heat Biologics Inc. in a research note on June 20, 2016. The analysts assigned a Buy rating to the stock. Noble Financial rated the stock as a Buy in a research noted published on January 08, 2016. H.C. Wainwright rated the stock as a Buy in a research note published on May 26, 2015.

HTBX Recent Trade

The share price of HTBX ascended by $0.16 during the exchanging session on 07/29/20 to exchange at $2.23. Heat Biologics Inc. stock has an exchanging volume of 115.38 million shares, which is high, contrasted with its 3-months average volume of 28.99M shares. Its market capitalization has now reached to $206.12M and analysts have a consensus target price of $4.00 in the 12-month period.

HTBX Past Trading Activity

The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, HTBX price has dropped by -24.92%. In the course of past three months sees the stock go up around 275.04%, while it has gain 771.43% over the past six months and 369.47% since the start of the year.

HTBX Earning History

Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), the firm recorded a revenue of 901.9 million, which was higher than the gauge of 270k made by certain experts. For that equivalent quarter, Heat Biologics Inc. posted -$0.11 earnings per share (EPS) which was underneath the consensus estimate of -$0.1 by -$0.01, which represents to a reduction by -10.00%.

HTBX Price Performance

Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Heat Biologics Inc. has seen its stock exchanging -48.14% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +331.33% above its three-month low. A more extensive look sees HTBX exchanging -48.14% beneath its 52-week high and 1043.59% above from its 52-week low price.

HTBX Instability & Beta Factor

The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 21.65%, while it has a month to month instability of 24.85%. The Firm has an ATR (Average True Range) of 0.49 and a beta factor of 0.88.

Leave a Comment